Several leading firms worldwide focus on the synthesis of complex drug APIs, notably Abacavir sulfate, Abarelix, and Abiraterone Mesylate. These substances present significant challenges in process building due to their molecular sophistication. The manufacturers of these APIs often employ sophisticated technologies and adhere to strict quality gui